Scientific Article
previous document  unige:11450  next document
add to browser collection

Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency

Ikinciogullari, Aydan
Zapata, D. A.
Dogu, Figen
Regueiro, J. R.
show hidden authors show all authors [1 - 9]
Published in Molecular Therapy. 2002, vol. 6, no. 6, p. 824-829
Abstract Major histocompatibility complex class II (MHCII) deficiency is a primary immunodeficiency resulting from defects in one of four different MHCII-specific transcription factors-CIITA, RFX5, RFXAP, and RFXANK. Despite this genetic heterogeneity, the phenotypical manifestations are homogeneous. It is frequently difficult to establish a definitive diagnosis of the disease on the basis of clinical and immunological criteria. Moreover, the phenotypical homogeneity precludes unambiguous identification of the regulatory gene that is affected. Identification of the four genes mutated in the disease has now allowed us to develop a rapid and straightforward diagnostic test for new MHCII-deficiency patients. This test is based on direct correction of the genetic defect by transduction of cells from patients with lentiviral vectors encoding CIITA, RFXANK, RFX5, or RFXAP. We have validated this approach by defining the molecular defects in two new patients. The RFXANK vector restored MHCII expression in a T cell line from one patient. The RFXAP vector corrected primary cells (PBL) from a second patient. Molecular analysis confirmed the presence of homozygous mutations in the RFXANK and RFXAP genes, respectively. Direct genetic correction represents a valuable tool for the diagnosis and classification of new MHCII-deficiency patients.
Keywords Amino Acid SequenceBase SequenceCell LineDNA-Binding Proteins/ genetics/metabolismFemaleGene TherapyGenetic Complementation TestGenetic Vectors/geneticsHistocompatibility Antigens Class II/ analysis/geneticsHumansImmunologic Deficiency Syndromes/classification/ diagnosis/ genetics/pathologyLentivirus/geneticsMaleMolecular Sequence DataNuclear ProteinsReproducibility of ResultsT-Lymphocytes/metabolismTrans-Activators/ genetics/metabolismTranscription Factors/ genetics/metabolismTransduction, Genetic
PMID: 12498778
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Other version:
Research group Transplantation immunologie et osteoimmunologie (561)
(ISO format)
MATHEUX, Franck et al. Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency. In: Molecular Therapy, 2002, vol. 6, n° 6, p. 824-829. doi: 10.1006/mthe.2002.0804

451 hits

0 download


Deposited on : 2010-08-27

Export document
Format :
Citation style :